| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/14/2015 | CN103045544B 预防西尼罗河病毒的重组假型杆状病毒Bac-G-prM/E及疫苗与应用 Prevention of West Nile virus pseudotyped recombinant baculovirus Bac-G-prM / E and vaccine applications |
| 01/14/2015 | CN102740877B 对源自hsp65的肽-6有特异性的人源化抗体及其方法和用途 -6 Hsp65 peptides originating from specific for humanized antibodies and methods and uses |
| 01/14/2015 | CN102481353B 用作疫苗的金黄色葡萄球菌DivIB Staphylococcus aureus as a vaccine DivIB |
| 01/14/2015 | CN102471380B 抗FcRH5抗体和免疫偶联物及使用方法 Anti FcRH5 antibodies and immune conjugates and method of use |
| 01/14/2015 | CN102451474B 一种miRNA的抗肿瘤作用、实施方法及用途 Antitumor effect one miRNA, implementation methods and uses |
| 01/14/2015 | CN102448485B 免疫原性组合物及其用途 The immunogenic compositions and uses |
| 01/14/2015 | CN102378767B 抗-fgfr3抗体及其使用方法 Anti -fgfr3 antibodies and methods of use |
| 01/14/2015 | CN102229605B 关于hiv整合酶的n-取代的羟基嘧啶酮甲酰胺抑制剂 N- about hiv integrase substituted hydroxy pyrimidinone carboxamide inhibitors |
| 01/14/2015 | CN102089001B 免疫诱导剂及癌的检测方法 Detection of immune-induced cancer agents |
| 01/14/2015 | CN102027013B 细胞外基质蛋白的氨基酸序列rgd的特异性人源化抗体及其应用 The amino acid sequence of extracellular matrix proteins rgd specific humanized antibodies and Applications |
| 01/14/2015 | CN101979404B H5亚型禽流感病毒保守中和表位模拟肽及其用途 H5 subtype avian influenza virus conserved neutralization epitope mimetics and their use |
| 01/14/2015 | CN101815531B 含细胞因子溶液的新组合物 The new composition of the solution containing cytokine |
| 01/14/2015 | CN101732348B 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途 Rabbit inflamed by vaccinia virus extract preparation acute cerebrovascular disease drugs in use |
| 01/13/2015 | US8933218 Conjugation process for PNAG and a carrier protein |
| 01/13/2015 | US8933211 Growth factor isoform |
| 01/13/2015 | US8933203 Vault and vault-like carrier molecules |
| 01/13/2015 | US8933202 AXL antibodies |
| 01/13/2015 | US8933111 Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester |
| 01/13/2015 | US8933050 Methods for the treatment and the diagnosis of cancer |
| 01/13/2015 | US8933041 System for treating and preventing breast cancer |
| 01/13/2015 | US8933038 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 01/13/2015 | US8933029 Antimicrobial and anti-inflammatory peptides |
| 01/13/2015 | US8933014 HJURP peptides and vaccines including the same |
| 01/13/2015 | US8933011 Treatment of preterm labor with toll-like receptor 9 antagonists |
| 01/13/2015 | US8932855 Immune Modulating Exosomes |
| 01/13/2015 | US8932852 Compositions and methods of treating inflammatory bowel disease |
| 01/13/2015 | US8932846 Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins |
| 01/13/2015 | US8932830 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/13/2015 | US8932821 NOGO receptor binding protein |
| 01/13/2015 | US8932715 Precipitation stabilising compositions comprising bioactive molecule and at least one cationic and one anionic precipitation stabilizing additives |
| 01/13/2015 | US8932633 Polysaccharide microparticles containing biological agents: their preparation and applications |
| 01/13/2015 | US8932609 Flagellin related polypeptides and uses thereof |
| 01/13/2015 | US8932608 Tuberculosis vaccine and method of using same |
| 01/13/2015 | US8932607 Batches of recombinant adenovirus with altered terminal ends |
| 01/13/2015 | US8932606 Chimeric pestivirus with insertion in 3′ nontranslated region (3′NTR) with stable replication and rnase resistance |
| 01/13/2015 | US8932605 Deletion mutants of flagellin and methods of use |
| 01/13/2015 | US8932604 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| 01/13/2015 | US8932603 Modified antibody |
| 01/13/2015 | US8932600 Modified tuberculosis antigens |
| 01/13/2015 | US8932599 Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines |
| 01/13/2015 | US8932598 Fusion proteins and methods of use |
| 01/13/2015 | US8932597 Human M2e peptide immunogens |
| 01/13/2015 | US8932596 Method of treating eosinophilic esophagitis |
| 01/13/2015 | US8932595 Nicotine immunonanotherapeutics |
| 01/13/2015 | US8932594 Adjuvants and methods of use |
| 01/13/2015 | US8932592 Compositions and methods for treating inflammatory disorders |
| 01/13/2015 | US8932591 Formulation of human antibodies for treating TNF-α associated disorders |
| 01/13/2015 | US8932590 Method of adsorbing transforming growth factor β |
| 01/13/2015 | US8932589 Methods and compositions using Kloto-FGF23 fusion polypeptides |
| 01/13/2015 | US8932588 Treatment of cancer involving mutated KRAS or BRAF genes |
| 01/13/2015 | US8932586 Modified forms of Pseudomonas exotoxin A |
| 01/13/2015 | US8932575 Compositions and methods for inducing migration by dendritic cells and an immune response |
| 01/13/2015 | CA2698079C A cell therapy method for the treatment of tumors |
| 01/13/2015 | CA2623429C Interleukin-13 antibody composition |
| 01/13/2015 | CA2603775C Method of protecting against staphylococcal infection |
| 01/13/2015 | CA2545325C Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 01/13/2015 | CA2540666C Glucocerebroside treatment of disease |
| 01/13/2015 | CA2489410C Molecular antigen arrays |
| 01/08/2015 | WO2015003122A2 Regulation of glucose metabolism using anti-cgrp antibodies |
| 01/08/2015 | WO2015003114A1 Soluble mic neutralizing monoclonal antibody for treating cancer |
| 01/08/2015 | WO2015003049A2 Compositions and methods to treat inflammatory joint disease |
| 01/08/2015 | WO2015002985A2 Fc coupled compositions and methods of their use |
| 01/08/2015 | WO2015002959A1 Vaccine comprising ama1 and ron2 |
| 01/08/2015 | WO2015002954A1 Synthetic oligosaccharides for p. aeruginosa vaccine |
| 01/08/2015 | WO2015002931A1 Compositions and methods for treating obesity |
| 01/08/2015 | WO2015002929A1 Methods and compositions for treating obesity |
| 01/08/2015 | WO2015002134A1 Cellular immunity inducing vaccine |
| 01/08/2015 | WO2015001532A1 Inhibition of the synthesis of beta-app or of the activity of the a‑beta peptide in the choroid plexus |
| 01/08/2015 | WO2015001526A1 Immunogenic peptides of the cyclin b1 tumour antigen |
| 01/08/2015 | WO2015001504A2 Antibody formulations and methods |
| 01/08/2015 | WO2015001361A1 Immunotherapy |
| 01/08/2015 | WO2015001345A1 Methods for treating cancer |
| 01/08/2015 | WO2015001277A1 Affinity chromatography matrix |
| 01/08/2015 | WO2015001128A1 Method of producing an inactivated lentivirus, especially hiv, vaccine, kit and method of use |
| 01/08/2015 | WO2015001085A1 Humanized or chimeric cd3 antibodies |
| 01/08/2015 | WO2015000832A1 Method for preparing virosomes |
| 01/08/2015 | WO2015000831A1 Method for preparing virosomes |
| 01/08/2015 | WO2015000624A1 Method for producing antibodies using ovine b-cells and uses thereof |
| 01/08/2015 | WO2015000059A1 Antibodies to toso |
| 01/08/2015 | WO2015000022A1 Treatment and prevention of mastitis |
| 01/08/2015 | US20150011732 Polymer conjugates of interferon beta-1a and uses |
| 01/08/2015 | US20150010946 Polynucleotides encoding zcytor17 ligand antibodies |
| 01/08/2015 | US20150010631 Immune-modifying nanoparticles for the treatment of inflammatory diseases |
| 01/08/2015 | US20150010599 Pharmaceutical formulation for reducing bladder spasms and method of use thereof |
| 01/08/2015 | US20150010597 Compositions and methods for vaccinating against hsv-2 |
| 01/08/2015 | US20150010596 Compositions and methods for vaccinating against hsv-2 |
| 01/08/2015 | US20150010595 Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule |
| 01/08/2015 | US20150010594 Hiv vaccine |
| 01/08/2015 | US20150010593 Methods and cells for the production of viral vaccines |
| 01/08/2015 | US20150010592 Capsular gram-positive bacteria bioconjugate vaccines |
| 01/08/2015 | US20150010591 Chlamydia antigen compositions and uses thereof |
| 01/08/2015 | US20150010587 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 01/08/2015 | US20150010586 p53 Peptide Vaccine |
| 01/08/2015 | US20150010583 Ex vivo nk cell differentiation from cd34+ hematopoietic cells |
| 01/08/2015 | US20150010581 Combined therapy of alpha-1-antitrypsin and temporal t-cell depletion for preventing graft rejection |
| 01/08/2015 | US20150010579 Treatment and Prevention of Gardnerella Vaginalis Infections |
| 01/08/2015 | US20150010575 Combination therapy for the treatment of cancer using an anti-c-met antibody |
| 01/08/2015 | US20150010574 Anti-igf antibodies |
| 01/08/2015 | US20150010570 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 01/08/2015 | US20150010569 Inhibitors Of Complement Activation |